Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E polymorphism and atherosclerosis.

J Davignon1, R E Gregg, C F Sing

  • 1Department of Lipid Metabolism and Atherosclerosis Research, Clinical Research Institute of Montreal, Quebec, Canada.

Arteriosclerosis (Dallas, Tex.)
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Placental blood flow and the risk of preterm delivery.

Placenta·2009
Same author

A PCSK9 variant and familial combined hyperlipidaemia.

Journal of medical genetics·2008
Same author

Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study.

Annals of human genetics·2007
Same author

Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.

Journal of internal medicine·2007
Same author

The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability.

Journal of molecular medicine (Berlin, Germany)·2006
Same author

Cardioprotective and other emerging effects of statins.

International journal of clinical practice. Supplement·2005
Same journal

Regulation of differentiated properties and proliferation of arterial smooth muscle cells.

Arteriosclerosis (Dallas, Tex.)·1990
Same journal

Calcium antagonists as anti-atherosclerotic agents.

Arteriosclerosis (Dallas, Tex.)·1990
Same journal

Are calcium ion antagonists effective anti-atherogenic agents?

Arteriosclerosis (Dallas, Tex.)·1990
Same journal

Arteriosclerosis: the first 10 years.

Arteriosclerosis (Dallas, Tex.)·1990
Same journal

Characterization in vitro of interaction of human apolipoprotein E-free high density lipoprotein with human hepatocytes.

Arteriosclerosis (Dallas, Tex.)·1990
Same journal

Vascular responses to endothelin-1 in atherosclerotic primates.

Arteriosclerosis (Dallas, Tex.)·1990
See all related articles

Apolipoprotein E (apo E) gene variations influence cholesterol levels and cardiovascular disease risk. Understanding apo E phenotypes aids in assessing individual cardiovascular risk and studying complex genetic interactions in hyperlipidemia.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • The apolipoprotein E (apo E) locus is a key determinant of plasma cholesterol variability in both healthy and diseased individuals.
  • Apo E gene polymorphism influences hyperlipidemia and susceptibility to atherosclerosis through complex gene-gene and gene-environment interactions.
  • Specific apo E alleles, such as E2 (protective) and E4 (predisposing to coronary artery disease), have differential impacts on cardiovascular health.

Purpose of the Study:

  • To elucidate the biological significance of apo E polymorphism in human health and disease.
  • To provide metabolic explanations for the differential effects of apo E alleles on lipoprotein metabolism and cardiovascular risk.
  • To highlight the clinical utility of determining apo E phenotype for cardiovascular risk assessment.

Related Experiment Videos

Main Methods:

  • Analysis of the apo E gene's coding region and its resulting protein products.
  • Investigation of the metabolic fate of lipoprotein particles influenced by apo E variants.
  • Comparative analysis of apo E2, E3, and E4 allele effects on lipoprotein levels and clearance.

Main Results:

  • Apo E2 exhibits lower receptor binding affinity, leading to delayed plasma clearance of associated lipoproteins.
  • Apo E4 shows altered distribution, faster degradation, and enhanced catabolism of VLDL and HDL particles, contributing to elevated LDL levels.
  • Significant, opposing impacts of apo E4 and E2 alleles on plasma LDL cholesterol concentrations were observed.

Conclusions:

  • Determination of apo E phenotype is a valuable adjunct for assessing an individual's cardiovascular risk profile.
  • The apo E polymorphism provides a model for studying complex genetic interactions in hyperlipidemia pathogenesis, particularly the epsilon 2 allele's association with type III hyperlipoproteinemia.
  • Further research into apo E and its interactions promises deeper understanding of atherosclerosis pathogenesis.